PT Diastika Biotekindo Tbk (IDX:CHEK)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
131.00
0.00 (0.00%)
At close: Feb 9, 2026

IDX:CHEK Income Statement

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22
171,944154,792129,098117,468
Revenue Growth (YoY)
33.19%19.90%9.90%-
Cost of Revenue
102,94296,74683,14176,290
Gross Profit
69,00258,04645,95641,178
Selling, General & Admin
47,72838,16733,56327,836
Other Operating Expenses
515.71515.71277.27120.65
Operating Expenses
48,24438,68333,84027,957
Operating Income
20,75919,36312,11713,221
Interest Expense
-393.39-258.55-32.73-0.15
Interest & Investment Income
434.15183.57260.67331.56
Currency Exchange Gain (Loss)
261.69261.69-514.78626.84
Other Non Operating Income (Expenses)
2,919-268.985,542-47.41
EBT Excluding Unusual Items
23,98019,28117,37114,132
Gain (Loss) on Sale of Assets
5.595.59169.22,627
Pretax Income
24,07519,28717,54016,759
Income Tax Expense
4,1124,1123,9503,723
Net Income
19,96215,17513,59113,035
Net Income to Common
19,96215,17513,59113,035
Net Income Growth
46.88%11.65%4.26%-
Shares Outstanding (Basic)
2,5122,5122,5122,512
Shares Outstanding (Diluted)
2,5122,5122,5122,512
EPS (Basic)
7.956.045.415.19
EPS (Diluted)
7.956.045.415.19
EPS Growth
46.88%11.65%4.26%-
Free Cash Flow
-10,949-1,9343,330534.23
Free Cash Flow Per Share
-4.36-0.771.330.21
Gross Margin
40.13%37.50%35.60%35.05%
Operating Margin
12.07%12.51%9.39%11.25%
Profit Margin
11.61%9.80%10.53%11.10%
Free Cash Flow Margin
-6.37%-1.25%2.58%0.46%
EBITDA
30,72726,97217,46018,775
EBITDA Margin
17.87%17.42%13.53%15.98%
D&A For EBITDA
9,9697,6095,3435,553
EBIT
20,75919,36312,11713,221
EBIT Margin
12.07%12.51%9.39%11.25%
Effective Tax Rate
17.08%21.32%22.52%22.22%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.